Life Sciences Archives - Page 27 of 27

AIRNA Secures $155 Million in Oversubscribed Series B Funding to Advance RNA Editing Therapies

April 1, 2025

MassBio Welcomes Six Members to 2025 Board of Directors

March 27, 2025

MassBio Honors Eli Lilly and RedPoint Oncology Among Others at its Annual Conference

March 27, 2025

THIS WEEK'S STORIES

Qfitlia Approved by FDA as First Therapy for Hemophilia A and B, With or Without Inhibitors

March 31, 2025

Maugel DeStefano Principal Jonathan Cocker to Discuss the Future of Health Care Facility Design at the Boston Life Sciences Conference on April 17

March 27, 2025

Arbutus Biopharma Implements Significant Workforce Reduction as Part of Strategic Restructuring

March 31, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences

Initial Speakers for Announced for Boston Life Sciences, Biotech, Pharma & Medical Facilities Conference 2025

Science Exchange Acquires HappiLabs to Enhance Scientific Procurement Capabilities

Charles River and Valo Health Discover Potential Lupus Treatment Using AI-Powered Drug Platform

Vertex Pharmaceuticals Announces Updates on Type 1 Diabetes Portfolio

Abbott Launches New Clinical Trial for Intravascular Lithotripsy to Improve Treatment of Coronary Artery Disease

Most Read

University Hospitals Cleveland Medical Center Deploys AI for Early Lung Cancer Detection

Geneoscopy Names Amit Bhalla as CFO to Drive Growth and Commercialization Efforts

RyCarma Therapeutics Appoints Dr. Elizabeth Tarka as Chief Medical Officer

Cognito Therapeutics’ Spectris Device Shows Promise in Preserving Brain Structure in Alzheimer’s Patients

EDITOR PICKS

AIRNA Secures $155 Million in Oversubscribed Series B Funding to Advance RNA Editing Therapies

MassBio Welcomes Six Members to 2025 Board of Directors

MassBio Honors Eli Lilly and RedPoint Oncology Among Others at its Annual Conference

THIS WEEK'S STORIES

Qfitlia Approved by FDA as First Therapy for Hemophilia A and B, With or Without Inhibitors

Maugel DeStefano Principal Jonathan Cocker to Discuss the Future of Health Care Facility Design at the Boston Life Sciences Conference on April 17

Arbutus Biopharma Implements Significant Workforce Reduction as Part of Strategic Restructuring

POPULAR CATEGORY

ABOUT US

FOLLOW US